Gerhard Grunder

Gerhard Gründer, psychiatrist and psychotherapist, is a professor at the Medical Faculty Mannheim of the University of Heidelberg. He heads the Department of Molecular Neuroimaging at the Central Institute of Mental Health in Mannheim. He is also the co-founder and medical director of the OVID Clinic Berlin. His research focuses on the neurobiology of mental disorders as well as molecular and clinical psychopharmacology. He uses functional imaging techniques, in particular positron emission tomography (PET). Central questions in his scientific work are those concerning the mechanisms of action of psychotropic drugs and the measurement and evaluation of their benefits. His most recent interest is the clinical evaluation of psychedelics in severe mental disorders, and he led the largest academically initiated clinical trial with a psychedelic drug (in treatment-resistant depression) ever conducted, the EPIsoDE study.